Vertex Pharmaceuticals (VRTX) Net Equity Issued and Repurchased (2009)
Vertex Pharmaceuticals (VRTX) posted quarterly Net Equity Issued and Repurchased of $488.1 million for Q4 2009, up 976300.0% quarter-over-quarter from -$50000.0 in Q2 2009.
Powered by 
Analysis
Vertex Pharmaceuticals (VRTX) Net Equity Issued and Repurchased (2009) Analysis & Trends
Vertex Pharmaceuticals' Net Equity Issued and Repurchased history runs 1 years deep, the most recent figure standing at $488.1 million for Q4 2009.
- In Q4 2009, Net Equity Issued and Repurchased changed N/A year-over-year to $488.1 million; the TTM figure through Dec 2009 stood at $801.3 million (changed N/A YoY), while the FY2009 annual figure was $801.4 million, changed N/A from the prior year.
- Net Equity Issued and Repurchased for Q4 2009 stood at $488.1 million, up from -$50000.0 in the prior quarter.
- The five-year high for Net Equity Issued and Repurchased was $488.1 million in Q4 2009, with the low at -$50000.0 in Q2 2009.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.77 Bn | 130.92 Bn | 2.84 Bn | - |
| 2 | Regeneron Pharmaceuticals | 85.51 Bn | 77.52 Bn | 3.93 Bn | 49.20 Mn |
| 3 | Argenx Se | 63.51 Bn | 58.32 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.20 Bn | 53.06 Bn | 52.00 Mn | - |
| 5 | Revolution Medicines | 44.04 Bn | 44.04 Bn | - | 141.90 Mn |
| 6 | BeOne Medicines | 39.99 Bn | 34.89 Bn | 1.53 Bn | - |
| 7 | Alnylam Pharmaceuticals | 35.45 Bn | 32.14 Bn | 992.69 Mn | - |
| 8 | Royalty Pharma | 28.40 Bn | 27.56 Bn | - | - |
| 9 | Insmed | 27.44 Bn | 26.28 Bn | 358.27 Mn | - |
| 10 | Incyte | 25.59 Bn | 21.05 Bn | 1.57 Bn | - |